Your browser doesn't support javascript.
loading
Comparative cost-effectiveness of mailed fecal immunochemical testing (FIT)-based interventions for increasing colorectal cancer screening in the Medicaid population.
Wheeler, Stephanie B; O'Leary, Meghan C; Rhode, Jewels; Yang, Jeff Y; Drechsel, Rebecca; Plescia, Marcus; Reuland, Daniel S; Brenner, Alison T.
Afiliación
  • Wheeler SB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • O'Leary MC; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Rhode J; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Yang JY; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Drechsel R; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Plescia M; Mecklenburg County Public Health Department, Charlotte, North Carolina.
  • Reuland DS; Association of State and Territorial Health Officials, Charlotte, North Carolina.
  • Brenner AT; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Cancer ; 126(18): 4197-4208, 2020 09 15.
Article en En | MEDLINE | ID: mdl-32686116
ABSTRACT

BACKGROUND:

Mailed reminders to promote colorectal cancer (CRC) screening by fecal immunochemical testing (FIT) have been shown to be effective in the Medicaid population, in which screening is underused. However, little is known regarding the cost-effectiveness of these interventions, with or without an included FIT kit.

METHODS:

The authors conducted a cost-effectiveness analysis of a randomized controlled trial that compared the effectiveness of a reminder + FIT intervention versus a reminder-only intervention in increasing FIT screening. The analysis compared the costs per person screened for CRC screening associated with the reminder + FIT versus the reminder-only alternative using a 1-year time horizon. Input data for a cohort of 35,000 unscreened North Carolina Medicaid enrollees ages 52 to 64 years were derived from the trial and microcosting. Inputs and outputs were estimated from 2 perspectives-the Medicaid/state perspective and the health clinic/facility perspective-using probabilistic sensitivity analysis to evaluate uncertainty.

RESULTS:

The anticipated number of CRC screenings, including both FIT and screening colonoscopies, was higher for the reminder + FIT alternative (n = 8131; 23.2%) than for the reminder-only alternative (n = 5533; 15.8%). From the Medicaid/state perspective, the reminder + FIT alternative dominated the reminder-only alternative, with lower costs and higher screening rates. From the health clinic/facility perspective, the reminder + FIT versus the reminder-only alternative resulted in an incremental cost-effectiveness ratio of $116 per person screened.

CONCLUSIONS:

The reminder + FIT alternative was cost saving per additional Medicaid enrollee screened compared with the reminder-only alternative from the Medicaid/state perspective and likely cost-effective from the health clinic/facility perspective. The results also demonstrate that health departments and state Medicaid programs can efficiently mail FIT kits to large numbers of Medicaid enrollees to increase CRC screening completion.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Análisis Costo-Beneficio Tipo de estudio: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Screening_studies Límite: Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Análisis Costo-Beneficio Tipo de estudio: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Screening_studies Límite: Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2020 Tipo del documento: Article